Amneal to Present at the 30th Annual Piper Jaffray Healthcare Conference

BRIDGEWATER, N.J., Nov. 21, 2018 /PRNewswire/ -- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) today announced that it will present at the Piper Jaffray Healthcare Conference in New York, NY, on Tuesday, November 27, 2018 at 1:00 p.m. ET.

To access a live webcast of the presentation, visit Amneal's Investor Relations Web site at https://investors.amneal.com/Investor-Relations.

An archived version will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days.

About Amneal

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is an integrated pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company has approximately 6,500 employees in its operations in North America, Asia, and Europe, working together to bring high-quality medicines to patients primarily within the United States.

Amneal is one of the largest and fastest growing generic pharmaceutical manufacturers in the United States, with an expanding portfolio of generic products to include complex dosage forms in a broad range of therapeutic areas. The Company also markets a portfolio of branded pharmaceutical products through its Specialty Pharma division focused principally on central nervous system disorders and parasitic infections. For more information, visit www.amneal.com.

Contact:
Mark Donohue
Investor Relations and Corporate Communications 
(908) 409-6718
www.amneal.com

SOURCE Amneal Pharmaceuticals, Inc.

Related Links

http://www.amneal.com